<DOC>
	<DOCNO>NCT00829816</DOCNO>
	<brief_summary>The purpose study evaluate safety tolerability dimebon give Alzheimer 's disease patient currently stable dose regimen memantine memantine plus donepezil .</brief_summary>
	<brief_title>Safety Tolerability Dimebon Patients Memantine , Memantine Plus Donepezil</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Memantine</mesh_term>
	<mesh_term>Donepezil</mesh_term>
	<criteria>Alzheimer 's disease On Memantine Caregiver willing accompany patient clinic visit Unstable medical illness significant hepatic renal disease Other primary psychiatric neurological disorder</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Alzheimers disease</keyword>
	<keyword>donepezil</keyword>
	<keyword>memantine</keyword>
</DOC>